Title: Pathology causing malignant biliary obstruction
1Pathology causing malignant biliary obstruction
- Carcinoma of duodenum
- Periampullary carcinoma
- Carcinoma of pancreas
- Lymphoma
- Carcinoma of gallbladder
- cystic duct LN, direct infiltration of CBD,
tumour fragments - Cholangiocarcinoma at hilum, Klatskin tumour
- HCC
- direct infiltration, compression, tumour
fragments in CBD
2Causes of mortality of MBO
- Cancer cachexia
- Liver failure
- Biliary sepsis
3Biliary obstructionPathophysiology
- Disruption of endoplasmic reticulum and
canalicular membrane - Destruction of hepatocytes
- ? reticulin ? collagen
- portal hypertension
4Biliary obstructionPathophysiology
- ? protein synthesis
- ? clotting factor synthesis
- Impaired gluconeogenesis
- Impaired ketogenesis
- ? endotoxaemia
- ? cell-mediated immunity
- ? reticulo-endothelial function
5Clinical manifestation of pathophysiological
effects of MBO
- Wound dehiscence
- Anastomotic dehiscence
- Bleeding tendency
- Malnutrition
- Sepsis
- in bile duct
- in other parts of body
- Renal failure
- Bleeding gastric erosions
6(No Transcript)
7(No Transcript)
8(No Transcript)
9(No Transcript)
10(No Transcript)
11(No Transcript)
12Selection of patients with MBO for surgeryWhy
surgery?
- Remove tumour
- Relieve obstruction
13Selection of patients with MBO for surgery
- Assessment of general status
- Assessment of tumour status
14Assessment of general status
- 1. Age
- 2. Concomitant medical diseases
- 3. Hidden medical illness
- ECG
- spirometry
- blood sugar
- renal function
- (Aim to define whether the patient is fit for
surgery)
15Assessment of tumour status
- Clinical examination
- US
- HAG
- CT scan
- MRI
- (Aim to define whether the tumour is still
confined to the organ of origin)
16Clinical examinationSigns of inoperability
Left supraclavicular lymph node Irregular surface
hepatomegaly Umbilical nodule Ascites Rectal-vesic
al pouch deposit
17Radiological examinationSigns of inoperability
Liver secondaries Lymph node metastases SMV/PV/SMA
encasement
18(No Transcript)
19(No Transcript)
20(No Transcript)
21(No Transcript)
22Laparotomy if
- 1. General condition is fit
- 2. Tumour is confined
- No promise of resection until laparotomy finding
shows no spread
23General status
Tumour status
bad
good
confined
spread
PTBD or endoprosthesis
PTBD or endoprosthesis
laparotomy
bypass if spread
radical resection if confined
24Radical resection of tumour causing MBOExamples
Whipple operation for carcinoma of pancreas,
ampulla, lower part of CBD or duodenum Right or
left hepatectomy together with confluence of
hepatic ducts for Klatskin tumour
25Bypass for MBO
- Single bypass
- choledochojejunostomy or hepaticojejunostomy
- Double bypass
- gastrojejunostomy
- Triple bypass
- pancreaticojejunostomy
26(No Transcript)
27Single bypass
28Double bypass
29Malignant biliary obstructionPostoperative
mortality
30Measures to reduce complications related to
surgery for MBO
- 1. Nutritional support
- 2. Vit K
- 3. FFP during surgery
- 4. Antibiotic cover
- 5. Mannitol, dopamine to prevent renal failure
- 6. H2 antagonist
31Measures to reduce postoperative complications
related to surgery for MBO
- 1. Preoperative PTBD
- 2. Preoperative endoscopic drainage
32Percutaneous transhepatic biliary drainage
33Endoprosthesis